LDL Apheresis for Arteriosclerosis Obliterans with Occluded Bypass Graft: Change in Prostacyclin and Effect on Ischemic Symptoms

Abstract

To study the mechanism of efficacy of low-density lipoprotein (LDL) adsorption for arte riosclerosis obliterans (ASO), eight ASO patients without indication for bypass surgery underwent LDL apheresis twice a week for 5 weeks and the change in prostaglandin I₂ (PGI₂) and thromboxane A₂ (TXA₂) due to LDL apheresis was measured. The concentra tion of 6-keto-PGF_I,, a metabolite of PGI₂, in systemic venous blood significantly increased from 10.4 ± 1.8 to 42.0 ± 10.6 pg/mL (P < 0.05) after one session of LDL apheresis, while no significant change of TXB₂, a metabolite of TXA₂, was encountered. The ratio of 6-keto-PGF,,,/TXB₂ also rose dramatically from 0.213 ±0.044 to 0.522 ±0.128 (P < 0.05) . In five patients, the ischemic clinical symptoms improved and both the concentration of 6-keto-PGF_1α and the ratio of 6-keto-PGF_1α/TXB₂ increased significantly, whereas in three patients there was no effect on clinical symptoms and neither parameter changed. These results suggest that elevated production of PGI₂ from vascular cells due to LDL apheresis might contribute to improvement of ischemic symptoms.

Get full access to this article

View all access options for this article.

References

Agishi T. , Kitano Y. , Suzuki T., et al : Improvement of peripheral circulation by low density lipoprotein adsorption Trans Am Soc Artif Intern Organs 35:349-351, 1989.

Agishi T. , Nakasato S. , Ota K. : Prognosis of patients with arteriosclerosis obliterans treated with LDL apheresis Vascular Surgery 28:513-517, 1994.

Sato Y. , Agishi T. : Low-density lipoprotein adsorption for arteriosclerotic patients Artif Organs 20:324-327, 1996.

Uno H. , Ueki Y. , Murashima J., et al : Removal of LDL from plasma by adsorption reduced adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance Atherosclerosis 116:93-102, 1995.

Takagi M. , Yamada T. , Yamaguchi H., et al : The role of low-density lipoprotein apheresis as postoperative care of bypass grafting for chronic arterial occlusion Cardiovasc Surg 4:459-465, 1996.

Rubba P. , Iannuzzi A. , Postiglione A., et al : Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia Circulation 81:610-616, 1990.

Agishi T. , Tanabe T. , Nishimura A., et al : LDL apheresis as a treatment of arteriosclerosis obliterans in the lower extremities: A multicenter study (abstract) J Jpn Coll Angiol 32:333-339, 1992.

Kojima S. , Harada-Shiba M. , Toyota Y., et al : Change in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis Int J Artif Organs 15:185-190, 1992.

Tojo K. , Sakai S. , Miyahara T. : Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS) Jpn J Nephrol 30:1153-1160, 1988.

10.

Tamai O. , Matsuoka H. , Itabe H., et al : Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans Circulation 95:76-82, 1997.

11.

Ueki Y. , Murashima J. , Matsunaga Y., et al : Generated bradykinin by LDL adsorption induces serum NO in patients with arteriosclerosis obliterans Jpn J Apheresis 15 (Suppl):S56, 1996.